Exhibit 99.1
JOINT FILING AGREEMENT
PURSUANT TO RULE 13D-1(K)(1)
The undersigned acknowledge and agree that the Statement on Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the American Depositary Shares, each representing two common shares, par value NT$10.00 per share, of Taiwan Liposome Company, Ltd., is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned that is named as a reporting person in such filing without the necessity of filing an additional joint filing agreement. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This joint filing agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
Dated: July 15, 2021
Chang-Hai Lin
/s/ Chang-Hai Lin
Yuhua Lin
/s/ Yuhua Lin
Chenghsien Lin
/s/ Chenghsien Lin
Tienhuo Chen
/s/ Tienhuo Chen
Chinpen Lin
/s/ Chinpen Lin
Taiping Wu
/s/ Taiping Wu
Chinnu Lin
/s/ Chinnu Lin
Yanhui Lin
/s/ Yanhui Lin
George Yeh
/s/ George Yeh
Keelung Hong
/s/ Keelung Hong
Leemei Chen
/s/ Leemei Chen
Topmunnity Therapeutics Taiwan Limited
By:/s/ Amy Huang
Name:Amy Huang
Title:Director
Champions Management Co., Ltd.
By:/s/ Amy Huang
Name:Amy Huang
Title:Director
Hongtai Investment Co., Ltd.
By:/s/ Charles Chen
Name:Charles Chen
Title:Director
